Amazonian Dance for Parkinson's (NCT06967493)
Improve walking through Amazonian dance
- Trial ID
- NCT06967493
- Official Title
- "Amazonian Dance for Parkinson": a Protocol Study for a Randomized Clinical Trial on Motor and Non-motor Symptoms of People With Parkinson's.
- Goal
- Improve walking through Amazonian dance
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Federal University of Rio Grande do Sul
- Study Type
- INTERVENTIONAL
- Enrollment
- 80 participants
- Conditions
- Parkinson Disease
- Interventions
- Amazonian Dance, Nordic Walking
Summary For Families
Goal: to see if a guided Amazonian Dance program can improve walking, balance, mood and thinking in people with mild to moderate Parkinson's, compared with a structured aerobic option. Approach: participants are randomized to Amazonian Dance, which uses music, rhythmic stepping, coordinated limb patterns and cognitive challenges to retrain timing, balance and gait, or to Nordic walking, which uses poles to boost posture and aerobic fitness; both are offered as add-on physical therapies alongside regular anti-Parkinson medications and do not replace levodopa or other drugs. Eligibility: adults 50 to 80 years old with Parkinson's at Hoehn and Yahr stages I to III who have been on anti-Parkinson drugs for at least a year and can follow instructions; people with recent surgery, DBS, pacemakers, other neurologic or serious chronic diseases, or lower-limb prostheses are excluded.
Locations
- Universidade Federal do Pará, Castanhal, Pennsylvania, Brazil
- Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Amazonian Dance. Goal: to see if a guided Amazonian Dance program can improve walking, balance, mood and thinking in people with mild to moderate Parkinson's, compared with a structured aerobic option. Approach: participants are randomized to Amazonian Dance, which uses music, rhythmic stepping, coordinated limb patterns and cognitive challenges to retrain timing, balance and gait, or to Nordic walking, which uses poles to boost posture and aerobic fitness; both are offered as add-on physical therapies alongside regular anti-Parkinson medications and do not replace levodopa or other drugs. Eligibility: adults 50 to 80 years old with Parkinson's at Hoehn and Yahr stages I to III who have been on anti-Parkinson drugs for at least a year and can follow instructions; people with recent surgery, DBS, pacemakers, other neurologic or serious chronic diseases, or lower-limb prostheses are excluded.
- Who can participate?
- Participants must be between 50 Years and 80 Years.
- Where is this trial located?
- This trial is recruiting at 2 locations.
- Does it cost anything to join?
- You are never charged a fee to join a legitimate clinical trial, and the study treatment and study-specific tests are provided by the trial sponsor at no charge. In the US, routine care you would receive anyway can still be billed to you or your insurance; coverage rules differ by country, and trials in the UK and Canada usually run through public health systems. Travel, parking, and time are real costs, and some trials reimburse them while others do not. Before enrolling, ask the study coordinator to explain in writing what is and is not covered.
- How long does the trial last?
- This trial is estimated to last approximately 4 months.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.
- Will I get a placebo in this trial?
- There is no placebo group. Everyone receives an active treatment; the study compares one treatment against another.
- How many visits does this trial involve?
- Participants will attend 24 sessions over 12 weeks (twice-weekly).